Monday, June 4, 2012

Google Alert - pharmaceutical news

News8 new results for pharmaceutical news
 
PharmStar Pharmaceuticals Update
MarketWatch (press release)
WILSON, NC, Jun 4, 2012 (GlobeNewswire via COMTEX) -- Howard Phykitt, President/CEO of PharmStar Pharmaceuticals, Inc. (OTN:PHAR) , would like to update all stockholders on the status of the company: "Contrary to rumors, I would like to inform all ...
See all stories on this topic »
AcelRx Pharmaceuticals Completes Private Placement of $10.0 Million
MarketWatch (press release)
REDWOOD CITY, Calif., June 4, 2012 /PRNewswire via COMTEX/ -- AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) , a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and ...
See all stories on this topic »
Onyx Pharmaceuticals and the University of Texas MD Anderson Cancer Center ...
MarketWatch (press release)
SOUTH SAN FRANCISCO, Calif. and HOUSTON, June 4, 2012 /PRNewswire via COMTEX/ -- Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) and The University of Texas MD Anderson Cancer Center today announced a non-exclusive research alliance for pre-clinical and ...
See all stories on this topic »
BioSante Pharmaceuticals, Inc. to Present at Jefferies Global Healthcare ...
MarketWatch (press release)
LINCOLNSHIRE, Ill., Jun 04, 2012 (BUSINESS WIRE) -- BioSante Pharmaceuticals, Inc. today announced that Stephen M. Simes, BioSante's president & CEO will present a corporate update at the Jefferies 2012 Global Healthcare Conference in New York on June ...
See all stories on this topic »
China Nuokang Bio-Pharmaceutical Inc. Appoints Lazard and Houlihan Lokey as ...
MarketWatch (press release)
BEIJING, Jun 4, 2012 (GlobeNewswire via COMTEX) -- China Nuokang Bio-Pharmaceutical Inc. (NASDAQ:NKBP) ("Nuokang" or the "Company"), a leading China-based biopharmaceutical company focused on the research, development, manufacture, marketing and sales ...
See all stories on this topic »
Adamas Pharmaceuticals Presents Update On Nurelin(TM) Program At Cambridge ...
MarketWatch (press release)
EMERYVILLE, Calif., June 4, 2012 /PRNewswire via COMTEX/ -- Adamas Pharmaceuticals, Inc., a privately held company, announced today that it will present an update on its Nurelin(TM) (amantadine HCl extended release capsules) program at the Cambridge ...
See all stories on this topic »
Pharmaceutical company opens HQ in Glenview
Chicago Sun-Times
AP June 4, 2012 9:50AM State and business officials are ready to open the relocated and revamped headquarters of Japanese pharmaceutical company Astellas Pharma. The company's headquarters for the Americas were in the Chicago suburb of Deerfield, ...
See all stories on this topic »
Adamas Pharmaceuticals Presents Update On Nurelin™ Program At Cambridge ...
Sacramento Bee
By Adamas Pharmaceuticals, Inc. EMERYVILLE, Calif., June 4, 2012 -- /PRNewswire/ -- Adamas Pharmaceuticals, Inc., a privately held company, announced today that it will present an update on its Nurelin™ (amantadine HCl extended release capsules) ...
See all stories on this topic »


This once a day Google Alert is brought to you by Google.

Delete this alert.
Create another alert.
Manage your alerts.

0 comments:

Post a Comment

Bullets

Total Pageviews

Pages

Twitter Delicious Facebook Digg Stumbleupon Favorites More

 
Design by Free WordPress Themes | Bloggerized by Lasantha - Premium Blogger Themes | Web Hosting Bluehost